Literature DB >> 34715426

Ketamine induces EEG oscillations that may aid anesthetic state but not dissociation monitoring.

Shubham Chamadia1, Jacob Gitlin1, Jennifer Mekonnen1, Breanna R Ethridge1, Reine Ibala1, Katia M Colon1, Jason Qu1, Oluwaseun Akeju2.   

Abstract

OBJECTIVE: Ketamine is an anesthetic drug associated with dissociation. Decreased electroencephalogram alpha (8-13 Hz) and low-beta (13-20 Hz) oscillation power have been associated with ketamine-induced dissociation. We aimed to characterize surface electroencephalogram signatures that may serve as biomarkers for dissociation.
METHODS: We analyzed data from a single-site, open-label, high-density surface electroencephalogram study of ketamine anesthesia (2 mg/kg, n = 15). We assessed dissociation longitudinally using the Clinician Administered Dissociation States Scale (CADSS) and administered midazolam to attenuate dissociation and enable causal inference. We analyzed electroencephalogram power and global coherence with multitaper spectral methods. Mixed effects models were used to assess whether power and global coherence signatures of ketamine could be developed into dissociation-specific biomarkers.
RESULTS: Compared to baseline, ketamine unresponsiveness was associated with increased frontal power between 0.5 to 9.3 Hz, 12.2 to 16.6 Hz, and 24.4 to 50 Hz. As subjects transitioned into a responsive but dissociated state (mean CADSS ± SD, 22.1 ± 17), there was a decrease in power between 0.5 to 10.3 Hz and 11.7 to 50 Hz. Midazolam reduced dissociation scores (14.3 ± 11.6), decreased power between 4.4 to 11.7 Hz and increased power between 14.2 to 50 Hz. Our mixed-effects model demonstrated a quadratic relationship between time and CADSS scores. When models (frontal power, occipital power, global coherence) were reanalyzed with midazolam and electroencephalogram features as covariates, only midazolam was retained.
CONCLUSIONS: Ketamine is associated with structured electroencephalogram power and global coherence signatures that may enable principled anesthetic state but not dissociation monitoring. SIGNIFICANCE: A neurophysiological biomarker for dissociation may lead to a better understanding of neuropsychiatric disorders.
Copyright © 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CADSS; Dissociation; EEG; Ketamine; Spectral

Mesh:

Substances:

Year:  2021        PMID: 34715426      PMCID: PMC8629941          DOI: 10.1016/j.clinph.2021.08.021

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  35 in total

1.  Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial.

Authors:  Serkan Sener; Cenker Eken; Carl H Schultz; Mustafa Serinken; Murat Ozsarac
Journal:  Ann Emerg Med       Date:  2011-02       Impact factor: 5.721

2.  Resting-state functional EEG connectivity in salience and default mode networks and their relationship to dissociative symptoms during NMDA receptor antagonism.

Authors:  Sara de la Salle; Joelle Choueiry; Dhrasti Shah; Hayley Bowers; Judy McIntosh; Vadim Ilivitsky; Brooke Carroll; Verner Knott
Journal:  Pharmacol Biochem Behav       Date:  2020-12-30       Impact factor: 3.533

3.  Piercing the Ketamine Cloud.

Authors:  Boris D Heifets
Journal:  Anesthesiology       Date:  2020-11-01       Impact factor: 7.892

4.  GABAA circuit mechanisms are associated with ether anesthesia-induced unconsciousness.

Authors:  Oluwaseun Akeju; Allison E Hamilos; Andrew H Song; Kara J Pavone; Patrick L Purdon; Emery N Brown
Journal:  Clin Neurophysiol       Date:  2016-02-27       Impact factor: 3.708

5.  Dissociative symptoms in panic disorder.

Authors:  S Ball; A Robinson; A Shekhar; K Walsh
Journal:  J Nerv Ment Dis       Date:  1997-12       Impact factor: 2.254

Review 6.  Neural oscillations demonstrate that general anesthesia and sedative states are neurophysiologically distinct from sleep.

Authors:  Oluwaseun Akeju; Emery N Brown
Journal:  Curr Opin Neurobiol       Date:  2017-05-22       Impact factor: 6.627

7.  Symptom subtypes of obsessive-compulsive disorder and their relation to dissociation.

Authors:  David Watson; Kevin D Wu; Cynthia Cutshall
Journal:  J Anxiety Disord       Date:  2004

Review 8.  Ketamine in pain management.

Authors:  Jan Persson
Journal:  CNS Neurosci Ther       Date:  2013-05-11       Impact factor: 5.243

9.  Recovery of consciousness and cognition after general anesthesia in humans.

Authors:  Michael S Avidan; Max B Kelz; George A Mashour; Ben Ja Palanca; Mathias Basner; Duan Li; Wei Wang; Stefanie Blain-Moraes; Nan Lin; Kaitlyn Maier; Maxwell Muench; Vijay Tarnal; Giancarlo Vanini; E Andrew Ochroch; Rosemary Hogg; Marlon Schwartz; Hannah Maybrier; Randall Hardie; Ellen Janke; Goodarz Golmirzaie; Paul Picton; Andrew R McKinstry-Wu
Journal:  Elife       Date:  2021-05-10       Impact factor: 8.140

10.  Electroencephalographic effects of ketamine on power, cross-frequency coupling, and connectivity in the alpha bandwidth.

Authors:  Stefanie Blain-Moraes; UnCheol Lee; SeungWoo Ku; GyuJeong Noh; George A Mashour
Journal:  Front Syst Neurosci       Date:  2014-07-01
View more
  1 in total

1.  Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat.

Authors:  Christien Bowman; Ulrike Richter; Christopher R Jones; Claus Agerskov; Kjartan Frisch Herrik
Journal:  Front Psychiatry       Date:  2022-01-27       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.